Table: begin end state 1 31 cytoplasmic 32 56 transmembrane 57 70 non-cytoplasmic 71 88 transmembrane 89 108 cytoplasmic 109 131 transmembrane 132 150 non-cytoplasmic 151 169 transmembrane 170 179 cytoplasmic 180 201 transmembrane 202 208 non-cytoplasmic 209 241 transmembrane 242 259 cytoplasmic 260 282 transmembrane 283 287 non-cytoplasmic 288 312 transmembrane 313 342 cytoplasmic 343 366 transmembrane 367 373 non-cytoplasmic 374 398 transmembrane 399 418 cytoplasmic 419 437 transmembrane 438 442 non-cytoplasmic 443 463 transmembrane 464 474 cytoplasmic 475 499 transmembrane 500 518 non-cytoplasmic 519 551 transmembrane 552 561 cytoplasmic 562 583 transmembrane 584 602 non-cytoplasmic 603 625 transmembrane 626 628 cytoplasmic
Input: >BPHYT_RS35765 FitnessBrowser__BFirm:BPHYT_RS35765 MSNHALNPADAGVPLHAASMPRRWLRSFDRGLIALVEVCAAALLMMEIVVMFAGVVCRYV LHQPLVWSDELAGILFLWLAMLGAVLALRRGEHMRMTALVSRLSPQRRAFVDTLAIAASI ALLALLIAPAYDYASGEAAIVTPALQISNAWRALALPIGAALMLLVGMIRLAQVSRVRDV VIVLAITAVLAAVAVFAGPWFQTLGKPNLVIFFVGVVAIGIFSGVPIGFSFALATFGYLG LSTFTPLEVVVGRMDEGMSHLVLLAVPLFVFLGLLIEMTGMARAMIEFLASLVGHVHGGL SFVLIGAMYLVSGISGSKVADMAAIAPVLFPEMKKRGASEGDLVALLATTGAQSETIPPS IVLITIGSVTGLSISALFTAGMLPGAVLALILCVVVWWRYRKEDLSGAQRFSKRQIGRLF VVSLPALALPFVIRMAVVEGVATATEVSTIGIAYSMLIGLVVYRRFEWRRLGRMLVDAAT LSGAILFIIGCATAMAWALTQSGFSQDLAQLMGSMPGGAYGFLAVSIVVFVMLGSVLEGI PAIVLFGPLLFPIARLAGVHEVHYAIVVILSMGVGLFSPPFGVGYYSACAISKVNPDAGI RPIVGYMGALIVGLIVVAAIPWISIGFL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server